Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia.
about
Atherosclerosis and atheroma plaque rupture: imaging modalities in the visualization of vasa vasorum and atherosclerotic plaquesInflammation and oxidative stress, rather than hypoxia, are predominant factors promoting angiogenesis in the initial phases of atherosclerosisSegmental heterogeneity of vasa vasorum neovascularization in human coronary atherosclerosis.Functional anatomy and hemodynamic characteristics of vasa vasorum in the walls of porcine coronary arteries.Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia.The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system.Pulmonary artery adventitial fibroblasts cooperate with vasa vasorum endothelial cells to regulate vasa vasorum neovascularization: a process mediated by hypoxia and endothelin-1.Vasa vasorum in atherosclerosis and clinical significanceThe dynamic vasa vasorum.Association of periarterial neovascularization with progression of cardiac allograft vasculopathy and long-term clinical outcomes in heart transplant recipients.Inflammatory angiogenesis in atherogenesis--a double-edged sword.The adventitia: Essential role in pulmonary vascular remodeling.Targeting the adventitial microenvironment in pulmonary hypertension: A potential approach to therapy that considers epigenetic change.Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells.Role of lipids and intraplaque hypoxia in the formation of neovascularization in atherosclerosis.Atherosclerosis and atheroma plaque rupture: normal anatomy of vasa vasorum and their role associated with atherosclerosis.
P2860
Q26827203-8D4D8227-356C-48E5-8721-91423C4E4EABQ28385112-1022B9D9-91DF-465C-9B03-E7BB1016E006Q33860139-B4AE81CF-DE03-404B-9A2B-3F6FD8A001D0Q34196137-0011E20A-F7AC-4F7E-96BE-8A5150D8E961Q34296762-E7CF351F-093C-48F9-A103-2A72F1F47A9CQ35001002-29D418D1-4E01-4EFB-B96E-82461C9090FFQ35088354-4DDA67C0-2442-4A4E-858A-4A1AE8E2B347Q35723904-CB9F19BC-10EA-412A-AAE1-602240791836Q36881789-7FF17D49-C7F9-470E-884F-33086C7BED59Q37029903-39EEA181-F5F2-4554-96AD-4CEAFBEB4D8BQ37209762-731821E5-4443-457D-BFA6-8EE38F9B9388Q38112032-401A3518-6FA8-4432-8EEB-AF50C684C7BDQ42145272-65EB4129-7141-4CFF-88F1-A0329C620A2DQ44445823-137B2113-52B8-4B94-B405-1BE8EBE79E76Q48257479-203A7E69-AA02-423D-A363-5EB922BD40BAQ55500889-6156EDEE-0CE4-4D52-8693-F4AB4758AB9B
P2860
Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Chronic endothelin receptor an ...... rimental hypercholesterolemia.
@en
Chronic endothelin receptor an ...... rimental hypercholesterolemia.
@nl
type
label
Chronic endothelin receptor an ...... rimental hypercholesterolemia.
@en
Chronic endothelin receptor an ...... rimental hypercholesterolemia.
@nl
prefLabel
Chronic endothelin receptor an ...... rimental hypercholesterolemia.
@en
Chronic endothelin receptor an ...... rimental hypercholesterolemia.
@nl
P2093
P1476
Chronic endothelin receptor an ...... rimental hypercholesterolemia.
@en
P2093
David R Holmes
Erik L Ritman
Joerg Herrmann
Patricia J Best
P304
P356
10.1016/S0735-1097(02)01798-9
P407
P577
2002-05-01T00:00:00Z